We have studied the fate of diabetic neuropathy and autonomic function in 13 patients with long standing Type 1 (insulin-dependent) diabetes mellitus following combined pancreas and kidney transplantation. Fifteen diabetic patients with a kidney graft only served as controls. After initial improvement of the neuropathy in both groups, probably caused by the elimination of uraemia, a continuous improvement during the 48 months study was seen in the euglycaemic pancreas graft recipients only. Autonomic (parasympathetic) function improved only slightly and to a similar extent in both groups.
Introduction
Polyneuropathy affecting motor, sensory and autonomic functions is common in patients with diabetes mellitus (cf Dyck et al, 1987) . The exact prevalence is not known, but is estimated to about 50 % after 25 years of Type 1 (insulin-dependent) diabetes mellitus (Pirart 1978) . Polyneuropathy and autonomic dysfunction are also common in end-stage uraemia (Arieff 1986; Thomas 1976 ) and thus, diabetic nephropathy may add to the already existing diabetic peripheral nerve dysfunction. We have earlier shown that two years of normoglycaemia after combined pancreatic and kidney transplantation (P+K-tx) resulted in only a minor improvement of the neuropathy and that the results did not differ significantly from a control group with a kidney transplant (Ktx) only. Furthermore, we found no improvement in autonomic function (R-R test) (Solders et al, 1987) . Similar results with halt of the expected progression, but little or slight improvement of the neuropathy in one to two year follow-up studies after pancreas vansplantation have been reported by others (Sutherland et ak 1986; Van der Vliet et al, 1988; Bartos et aL 1986; Traeger et al. 1986; Landgraf et al, 1986; Beggs et al, 1990) . Recently, Kennedy et alo(1990) reported a tendency towards improvement of the neuropathy in 11 patients studied 42 months after pancreas transplantation, whereas in the insulin-treated control group the neuropathy tended to worsen.
The aim of this study was to examine whether four years of normoglycaemia after combined P+K-tx could halt the progression of the neuropthy, or even restore peripheral nerve function and autonomic functions. A control group of diabetic patients with a renal graft only was included to see if the changes found could be due to the curing of uraemia or whether an additional improvement could be observed which could be due to the normoglycaemia induced by the pancreatic transplantation.
Subjects and methods
Eighteen patients undergoing combined P+K-tx were initially admitted to the study. Five patients were excluded during the study, 2 because they died (intracerebral haemorraghia, cardiac infarction) and 3 because of late pancreas graft rejection. Thus, 13 patients (9 male, 4 female) aged 30-44 remained in the study for at least 4 years. 4/13 patients were on dialysis prior to P+K tx.
The control group consisted of 18 patients who lost their pancreatic graft early or who received a K-tx only (4 patients). Three control patients were excluded during the study, 2 because they died (cardiac failure, cardiac infarction) and 1 because of late renal graft rejection. The remaining 15 control patients (8 male, 7 female) aged 30-53 remained in the study for at least 4 years. 13/15 of the control subjets were on dialysis prior to K-tx.
All patients had long standing Type 1 diabetes mellitus (25 +4 years in the K+P-tx group, 26 +7 years in the control K-tx group).
Transplantation. The surgical technique has been described earlier (Groth et al, 1982; Tyd~n et al, 1986) . Enteric S126 diversion of the exocrine secretion was used. All pancreatic grafts were obtained from eadaveric donors and for the combined tx the kidney came from the same donor. For renal transplantation alone, 16 kidneys came from eadaveric donors and 2 from living related donors. Immunosupression consisted of cyclosporine, azathioprine, prednisolone and rabbit anti-thymocyte globuline. Rejection was treated with methylprednisolone iv for 4 days.
Recording procedure. Nerve conduction studies were with conventional neurophysiologieal techniques. Ten variables were recorded: motor conduction velocity (MCV) and distal latency (DL) in the median and peroneal nerves and sensory conduction velocity (SCV) and the amplitude of the sensory nerve action potential (SNAP) in the distal and proximal median nerve and in the sural nerve. Care was taken to make all recordnings at normal skin temperature. The R-R variations in the electrocardiogram were recorded and the variations relative to mean R-R interval during 1 min of deep breathing (6 breaths/min) were calculated. Our normal value for this age group is 30 +9 %. Recording procedure and calculations have been described earlier (Persson and Solders 1983) .
Statistical methods.
Values are given as mean +SD. The degree of polyneuropathy was expressed as an index, ENeG-Ix, which is the mean deviation of the recorded variables (in SD) from normal age-matched laboratory controls. The normal limit of ENeG-Ix for individuals (p<0.05) is +2/~/number of recorded variables, in this study ie. +0.63. Differences between the groups were tested by the two-tailed t-test and intraindividual differences over time were tested by the two-tailed t-test of differences. The level of significance was set to p<0.05 (Snedecor and Cochran 1980) .
Results
Exogenous insulin could be discontinued in all patients in the P+K-tx group. Glycosylated haemoglobin, HbAlc, was normal (<5%) in 8 patients and near normal (<7%) in 5 patients. The mean value was 4.9 +0.5. In the K-tx group the I-IbAle level was near normal in one patient but elevated in the remaining 14. The mean value was 9.5 +2.0. S-kreatinin levels were moderately elevated in both groups after four years (233 +192 in the P+K-tx and 228 +104 I~mol/1 in the K-tx group, normal <115 lxmol/1).
Before tx, all patients had neurophysiological signs of moderate or severe polyneuropathy. The ENeG-Ix indicated a slightly, but not significantly, more marked neuropathy in the control (K-tx) group (-2.89 +0.76) compared to the P+K-tx group (-2.52 +0.75). After the transplantation both groups improved in ENeG-Ix.
Within the P+K-tx group a significant (p<0.01) improvement in ENeG-Ix was seen after 24 months and continous additional improvement was seen up to 48 months (p<0.001). In the K-tx group an initial improvement (p<0.01) of ENeG-Ix was seen during the first 24 months, after which no further improvement was seen, but instead a slight deterioration. After four years the ENeG-Ix in the P+K-tx group was -1.79 +0.72 vs -2.25 +__0.81 in the control K-tx groun.
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Even after 48 months all patients except one (in the P+K-tx group) still had ENeG-Ix indicative of neuropathy. The difference in ENeG-Ix between the groups never reached significance (mean difference 0.46 SD after 48 months). Significant intraindividual improvement of the ENeG-Ix (>+0.63 SD, ie. p<0.05) was seen in 9/13 (mean +0.73 SD) in the P+K-tx group and in 7/15 (mean +0.64 SD) in the K-tx group.
The R-R variation during deep breathing was equally low in both groups (p<0.001 vs laboratory age-matched controls) before the transplantation.
After the transplantation a slight improvement (p<0.05) was seen in both groups between 0 -48 months.
Discussion
This prospective study shows that diabetic neuropathy had improved 48 months after combined pancreatic and renal transplantation. Intraindividual improvement over time was more marked in the study group as compared to the control group receiving a renal graft only. The initial improvement in the control group can probably be explained by the fact that it conthined more patients on dialysis prior to tx than did the P+K-tx group (13/15 vs 4/13) and, thus, the control patients probably had a larger component of uraemic neuropathy that responded to the renal tx. Furthermore, the patients in the P+K-tx group continued to improve throughout the study, whereas the ENeG-Ix in the still diabetic K-tx group deteriorated during the last two years. Thus, although the initial improvement seen in both groups may well be a result of the elimination of uraemia, the course between 24 and 48 months demonstrates that the normoglycaemic pancreas tx recipients were further able to improve their nerve function, whereas the still diabetic renal tx group could not.
Other studies on nerve function one to two years following pancreas tx have shown similar results, with a halt of the progression of neuropathy (Solders et al, 1987; Sutherland et al~ 1986; Van der Vliet et ah 1988; Bartos et al, 1986; Traeger et al, 1986; Landgraf et al~ 1986; Beggs et al. 1990) . Recently, Kennedy et al, (1990) , using similar techniques to ours, found improvement in nerve function 12 months (61 patients), 24 months (27 patients) and a slight but not significant improvement 42 months (11 patients) after pancreas tx (in most cases without a simultaneous kidney graft).
The autonomic function was assessed by the R-R variation test during deep breathing. This is a sensitive test of the parasympathetic vagal reflex arc both in diabetes (Ewing et a1,1981) and in uraemia (Solders et al~ 1986) , providing that consideration is taken to age (Wieling et al, 1982; Persson and Solders 1983; S~lberg and Nogu6s 1989) . The autonomic dysfunction was severe in all patients before tx and only a minor improvement was seen after four years (but not earlier) which was similar in both groups. In contrast to somatic nerve function (ENeG), impaired R-R variations in non-diabe-G. Solders et al.: Diabetic neuropathy after pancreatic transplantation tic uraemic patients do not improve within one year after renal transplantation (Solders et al. 1986 ). The cause of the improvement in R-R variations in both our groups may be a long-term effect of the elimination of uraemia. An additional effect of four years euglycaemia in the pancreas tx group could explain the slight, but not significant, additional improvement in this group. Kennedy et aL(1990) found a slight, but not significant, improvement in autonomic tests (R-R variation and Valsalva) 42 months after pancreas tx and the same group also reported no improvement in small nerve fibre functions (sweating and temperature) two years after pancreas tx (Kennedy et al, 1989) . Thus, in diabetic neuropathy thin myelinated and unmyelinated nerve fibres seem to recover less or at a slower rate than thick myelinated fibres after pancreas Ix.
In conclusion: combined pancreatic and renal transplantation in patients with long standing Type 1 diabetes mellitus improved peripheral nerve function. An initial improvement was probably due to the elimination of uraemia. Subsequently further improvement was seen, probably due to nerve repair and regeneration under euglycaemia. Autonomic (parasympathetic) function improved only slightly and not more after combined transplantation than after kidney transplantation alone.
